Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This study will look at the change in the participant's body weight from the start to the end
of the study. This is to compare the effect on body weight in people taking semaglutide (a
new medicine) and people taking "dummy" medicine. In addition to taking the study medicine,
the participant will have talks with study staff about healthy food choices, how to be more
physically active and what else the participant can do to lose weight. Overweight and obesity
is associated with an increased risk of type 2 diabetes. Therefore, weight loss has shown to
have a beneficial impact on the blood sugar levels. The participant will either get
semaglutide or "dummy" medicine - which treatment the participant get is decided by chance.
The participant will need to take 2 injections at the same time once a week. The study
medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm.
The study will last for about 1.5 years